Table 1.
Characteristic | Value |
---|---|
Age, yr | 61.8±9.4 |
Sex | |
Male | 183 (71.2) |
Female | 74 (28.8) |
Family history of gastric cancer* | |
No | 199 (77.4) |
Yes | 50 (19.5) |
Smoking status | |
Never | 102 (39.7) |
Past | 113 (44.0) |
Current | 42 (16.3) |
H. pylori infection status | |
Never | 30 (11.7) |
Past | 69 (26.8) |
Current | 158 (61.5) |
Gastric atrophy by serum pepsinogen test* | |
Not severe | 209 (81.3) |
Severe† | 44 (17.1) |
IM (antrum) | |
Absent or mild | 125 (48.6) |
Moderate or severe | 132 (51.4) |
IM (body) | |
Absent or mild | 188 (73.2) |
Moderate or severe | 69 (26.8) |
Type of gastric neoplasm | |
Low-grade dysplasia | 113 (44.0) |
High-grade dysplasia | 25 (9.7) |
Early gastric cancer | 119 (46.3) |
No. of neoplasm | |
Single | 239 (93.0) |
Multiple | 18 (7.0) |
Location of neoplasm | |
Upper or middle third | 63 (24.5) |
Lower third | 194 (75.5) |
Size of neoplasm, cm | 1.2±0.8 |
Type of endoscopic resection | |
Endoscopic mucosal resection | 164 (63.8) |
Endoscopic submucosal dissection | 93 (36.2) |
Data are presented as mean±SD or number (%).
H. pylori, Helicobacter pylori; IM, intestinal metaplasia.
The data regarding the family history of gastric cancer were missing in eight patients, and the serum pepsinogen test was not performed in four patients;
Severe atrophy was defined as pepsinogen I ≤30 and pepsinogen I/II ≤2.0.